Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Helen LavretskyDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. hlavretsky@mednet.ucla.edu.ORCID http://orcid.org/0000-0001-9990-5085
Sahib KhalsaDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.ORCID http://orcid.org/0000-0003-2124-8585
Hanadi Ajam OughliDepartment of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
Josefina CruzatLatin American Brain Health Institute (BrainLat), Universidad Adolfo Ibañez, Santiago, Chile.
Emmeline EdwardsWorld Women in Neuroscience, 501(c)(3); retired as of 5/31/2025, National Center for Complementary and Integrative Health (until May 27, 2025), Ellicott city, MD, USA.
Paul NewhouseDepartment of Psychiatry and Behavioral Sciences, Center for Cognitive Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-9298-7185
Claudio L A BassettiDepartment of Neurology, Medical Faculty, University of Bern, Inselspital, Bern, Switzerland.
Indrit BegueDepartment of Psychiatry, Laboratory for Neuroimaging and Translational Psychiatry, University of Geneva and University Hospitals of Geneva, Geneva, Switzerland.ORCID http://orcid.org/0000-0001-5350-4454
Andrea S WinklerDepartment of Neurology, TUM University Hospital, and Center for Global Health, TUM School of Medicine and Health, Technical University of Munich (TUM), Munich, Germany.
Dilip V JesteSocial Determinants of Health Network, La Jolla, CA, USA.
Harris A EyreDepartment of Psychological Sciences, Office of Innovation, Center for Health, Baker Institute for Public Policy, School of Engineering, Rice University, Houston, TX, USA.ORCID http://orcid.org/0000-0003-4827-8258
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Correction: The role of brain health and resilience in reshaping trajectories of late-life neuropsychiatric disorders. · full record | OpenQuestion